Cargando…

Efficacy of different strategies to treat anemia in children: a randomized clinical trial

BACKGROUND: Anemia continues to be a major public health problem among children in many regions of the world, and it is still not clear which strategy to treat it is most effective. OBJECTIVE: To evaluate the efficacy and children's acceptance of several recognized strategies to treat anemia. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosado, Jorge L, González, Karla E, Caamaño, María del C, García, Olga P, Preciado, Roxana, Odio, Mauricio
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955680/
https://www.ncbi.nlm.nih.gov/pubmed/20863398
http://dx.doi.org/10.1186/1475-2891-9-40
_version_ 1782188067323379712
author Rosado, Jorge L
González, Karla E
Caamaño, María del C
García, Olga P
Preciado, Roxana
Odio, Mauricio
author_facet Rosado, Jorge L
González, Karla E
Caamaño, María del C
García, Olga P
Preciado, Roxana
Odio, Mauricio
author_sort Rosado, Jorge L
collection PubMed
description BACKGROUND: Anemia continues to be a major public health problem among children in many regions of the world, and it is still not clear which strategy to treat it is most effective. OBJECTIVE: To evaluate the efficacy and children's acceptance of several recognized strategies to treat anemia. METHODS: Non-breastfed children (n = 577), 6 to 43 mo of age, were screened for the trial; 267 were anemic (hemoglobin < 11.7 g/dL), and 266 of those were randomized into 1 of 5 treatments to received daily either: an iron supplement (IS), an iron+folic acid supplement (IFS), a multiple micronutrient supplement (MMS), a micronutrient-fortified complementary food as porridge powder (FCF), or zinc+iron+ascorbic acid fortified water (FW). The iron content of each daily dose was 20, 12.5, 10, 10 and 6.7 mg respectively. Hemoglobin (Hb), ferritin, total iron, weight and height were measured at baseline and after 4 months of treatment. Morbidity, treatment acceptability and adherence were recorded during the intervention. RESULTS: All treatments significantly increased Hb and total iron concentration; ferritin did not change significantly. Groups MMS, IS and IFS increased Hb (g/dL) [1.50 (95%CI: 1.17, 1.83), 1.48 [(1.18, 1.78) and 1.57 (1.26, 1.88), respectively] and total iron ((μg/dL) [0.15 (0.01, 0.29), 0.19 (0.06, 0.31) and 0.12(-0.01, 0.25), respectively] significantly more than FCF [0.92 (0.64, 1.20)] but not to FW group [0.14 (0.04, 0.24)]. The prevalence of anemia was reduced to a greater extent in the MMS and IFS groups (72% and 69%, respectively) than in the FCF group (45%) (p < 0.05). There were no significant differences in anthropometry or in the number of episodes of diarrhea and respiratory infections among treatment groups. The supplements MMS and IS were less acceptable to children, than IFS, FCF and FW. CONCLUSION: The three supplements IS, ISF and MMS increased Hb more than the FCF; the supplements that contained micronutrients (IFS and MMS) were more effective for reducing the prevalence of anemia. In general, fortified foods were better accepted by the study participants than supplements. CLINICALTRIAL.GOV IDENTIFIER: NCT00822380
format Text
id pubmed-2955680
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29556802010-10-16 Efficacy of different strategies to treat anemia in children: a randomized clinical trial Rosado, Jorge L González, Karla E Caamaño, María del C García, Olga P Preciado, Roxana Odio, Mauricio Nutr J Research BACKGROUND: Anemia continues to be a major public health problem among children in many regions of the world, and it is still not clear which strategy to treat it is most effective. OBJECTIVE: To evaluate the efficacy and children's acceptance of several recognized strategies to treat anemia. METHODS: Non-breastfed children (n = 577), 6 to 43 mo of age, were screened for the trial; 267 were anemic (hemoglobin < 11.7 g/dL), and 266 of those were randomized into 1 of 5 treatments to received daily either: an iron supplement (IS), an iron+folic acid supplement (IFS), a multiple micronutrient supplement (MMS), a micronutrient-fortified complementary food as porridge powder (FCF), or zinc+iron+ascorbic acid fortified water (FW). The iron content of each daily dose was 20, 12.5, 10, 10 and 6.7 mg respectively. Hemoglobin (Hb), ferritin, total iron, weight and height were measured at baseline and after 4 months of treatment. Morbidity, treatment acceptability and adherence were recorded during the intervention. RESULTS: All treatments significantly increased Hb and total iron concentration; ferritin did not change significantly. Groups MMS, IS and IFS increased Hb (g/dL) [1.50 (95%CI: 1.17, 1.83), 1.48 [(1.18, 1.78) and 1.57 (1.26, 1.88), respectively] and total iron ((μg/dL) [0.15 (0.01, 0.29), 0.19 (0.06, 0.31) and 0.12(-0.01, 0.25), respectively] significantly more than FCF [0.92 (0.64, 1.20)] but not to FW group [0.14 (0.04, 0.24)]. The prevalence of anemia was reduced to a greater extent in the MMS and IFS groups (72% and 69%, respectively) than in the FCF group (45%) (p < 0.05). There were no significant differences in anthropometry or in the number of episodes of diarrhea and respiratory infections among treatment groups. The supplements MMS and IS were less acceptable to children, than IFS, FCF and FW. CONCLUSION: The three supplements IS, ISF and MMS increased Hb more than the FCF; the supplements that contained micronutrients (IFS and MMS) were more effective for reducing the prevalence of anemia. In general, fortified foods were better accepted by the study participants than supplements. CLINICALTRIAL.GOV IDENTIFIER: NCT00822380 BioMed Central 2010-09-23 /pmc/articles/PMC2955680/ /pubmed/20863398 http://dx.doi.org/10.1186/1475-2891-9-40 Text en Copyright ©2010 Rosado et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Rosado, Jorge L
González, Karla E
Caamaño, María del C
García, Olga P
Preciado, Roxana
Odio, Mauricio
Efficacy of different strategies to treat anemia in children: a randomized clinical trial
title Efficacy of different strategies to treat anemia in children: a randomized clinical trial
title_full Efficacy of different strategies to treat anemia in children: a randomized clinical trial
title_fullStr Efficacy of different strategies to treat anemia in children: a randomized clinical trial
title_full_unstemmed Efficacy of different strategies to treat anemia in children: a randomized clinical trial
title_short Efficacy of different strategies to treat anemia in children: a randomized clinical trial
title_sort efficacy of different strategies to treat anemia in children: a randomized clinical trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2955680/
https://www.ncbi.nlm.nih.gov/pubmed/20863398
http://dx.doi.org/10.1186/1475-2891-9-40
work_keys_str_mv AT rosadojorgel efficacyofdifferentstrategiestotreatanemiainchildrenarandomizedclinicaltrial
AT gonzalezkarlae efficacyofdifferentstrategiestotreatanemiainchildrenarandomizedclinicaltrial
AT caamanomariadelc efficacyofdifferentstrategiestotreatanemiainchildrenarandomizedclinicaltrial
AT garciaolgap efficacyofdifferentstrategiestotreatanemiainchildrenarandomizedclinicaltrial
AT preciadoroxana efficacyofdifferentstrategiestotreatanemiainchildrenarandomizedclinicaltrial
AT odiomauricio efficacyofdifferentstrategiestotreatanemiainchildrenarandomizedclinicaltrial